Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025)
Cabaletta Bio's (CABA) quarterly Exchange Rate Effect came in at -$8000.0 in Q4 2025, up 60.0% year-on-year from -$5000.0 in Q4 2024, and up 27.27% quarter-over-quarter from -$11000.0 in Q3 2025.
Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025) Analysis & Trends
Cabaletta Bio's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$8000.0 for Q4 2025.
- On a quarterly basis, Exchange Rate Effect rose 60.0% year-over-year to -$8000.0 in Q4 2025; TTM through Dec 2025 was $19000.0, a 195.0% increase from a year earlier, with the FY2025 full-year figure at $19000.0, up 195.0% from the prior year.
- Exchange Rate Effect improved to -$8000.0 in Q4 2025 per CABA's latest filing, from -$11000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $31000.0 in Q2 2025 and bottomed at -$20000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |